Mountain View, CA – According to filings with the U.S. Securities and Exchange Commission, Materna Medical is raising $22,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Tracy Macneal played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Materna Medical
Materna Medical is a novel OBGYN platform company, defining a $6B market in the most common pelvic conditions women face. Our first product, Milli, is a vaginal and pelvic floor dilator with adjustable, incremental sizing for women who are trying to achieve intimate health. Milli launched in 2019 with a direct-to-consumer sales approach through ecommerce and healthcare professionals referrals. Our second product, Materna Prep, is currently in clinical trials to see if we can help first-time moms achieve less pelvic muscle injuries and a shorter length of delivery during childbirth.

To learn more about Materna Medical, visit http://www.maternamedical.com/

Contact:
Tracy Macneal, President and Chief Executive Officer
415-254-1031

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved